Updated Jul 16, 2026
Flammer Martina M.D. has filed 4 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $40.32M.
Martina M.D. Flammer is the Chief Medical Officer at Insmed Inc, a biopharmaceutical company focused on treating serious and rare diseases. She has been involved in multiple SEC filings related to her role at the company.
| Role | Chief Medical Officer |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-08 | INSM | INSMED Inc | S — Open-market sale | 7.4K | $110.60 | $824K |
| 2026-07-08 | INSM | INSMED Inc | S — Open-market sale | 4.9K | $109.02 | $529K |
| 2026-07-08 | INSM | INSMED Inc | M — Option exercise | 4.4K | $19.74 | $86K |
| 2026-07-08 | INSM | INSMED Inc | M — Option exercise | 7.9K | $29.13 | $231K |
| 2026-06-05 | INSM | INSMED Inc | S — Open-market sale | 1.9K | $103.78 | $193K |
| 2026-06-05 | INSM | INSMED Inc | S — Open-market sale | 2.6K | $102.27 | $262K |
| 2026-05-15 | INSM | INSMED Inc | S — Open-market sale | 10.5K | $117.54 | $1.23M |
| 2026-05-15 | INSM | INSMED Inc | S — Open-market sale | 3.4K | $116.18 | $393K |
| 2026-05-15 | INSM | INSMED Inc | S — Open-market sale | 4.5K | $112.76 | $504K |
| 2026-05-13 | INSM | INSMED Inc | S — Open-market sale | 830 | $101.18 | $84K |
| 2026-05-13 | INSM | INSMED Inc | S — Open-market sale | 12.1K | $100.35 | $1.22M |
| 2026-05-13 | INSM | INSMED Inc | M — Option exercise | 12.9K | $17.07 | $221K |
| 2026-02-06 | INSM | INSMED Inc | S — Open-market sale [10b5-1] | 869 | $152.44 | $132K |
| 2026-02-04 | INSM | INSMED Inc | S — Open-market sale [10b5-1] | 795 | $155.77 | $124K |
| 2026-02-04 | INSM | INSMED Inc | S — Open-market sale [10b5-1] | 100 | $156.86 | $16K |
| 2026-02-04 | INSM | INSMED Inc | S — Open-market sale [10b5-1] | 3.0K | $155.46 | $473K |
| 2026-02-04 | INSM | INSMED Inc | S — Open-market sale [10b5-1] | 3.3K | $154.56 | $518K |
| 2026-02-04 | INSM | INSMED Inc | S — Open-market sale [10b5-1] | 928 | $153.16 | $142K |
| 2026-02-04 | INSM | INSMED Inc | S — Open-market sale [10b5-1] | 563 | $152.06 | $86K |
| 2026-02-04 | INSM | INSMED Inc | M — Option exercise [10b5-1] | 8.0K | $65.72 | $525K |
Martina M.D. Flammer is the Chief Medical Officer at Insmed Inc, a biopharmaceutical company focused on treating serious and rare diseases. She has been involved in multiple SEC filings related to her role at the company.…
4 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 30 open-market sales ($40.32M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Flammer Martina M.D. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.